WuXi AppTec (2359.HK) Financial Analysis & Valuation | Quarter Chart
WuXi AppTec (2359.HK)
2359.HKPrice: $19.6
Fair Value: 🔒
🔒score
WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, rest of Asia, the United States, Europe, and internationall... more
WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufactur... more
Description
Shares
| Market Cap | $56.42B | Exchange | HKSE |
| Sector | Healthcare | Industry | Medical - Diagnostics & Research |
| Country | CN | CEO | Ge Li |
| IPO Date | 2018-12-13 | CAGR | 0.24% |
| Employees | 39,414 | Website | www.wuxiapptec.com |
| Div. Yield | 0.29% | Payout Ratio | 0.3% |
| Buy Back Yield | 1% | Total Yield | 1.29% |
2359.HK chart loading...
Fundamentals
Technicals
| Enterprise Value | $283.29B | P/E Ratio | 19.58 |
| Forward P/E | 20.99 | PEG Ratio | 0.78 |
| P/S Ratio | 6.42 | P/B Ratio | 4.36 |
| P/CF Ratio | 20.39 | P/FCF Ratio | 25.91 |
| EPS | $1 | EPS Growth 1Y | 79.59% |
| EPS Growth 3Y | 129.37% | EPS Growth 5Y | 369.59% |
| Revenue Growth 1Y | 17.86% | Gross Margin | 0.49% |
| Operating Margin | 0.43% | Profit Margin | 0.42% |
| ROE | 0.27% | ROA | 0.19% |
| ROCE | 0.23% | Current Ratio | 3.42 |
| Quick Ratio | 2.9 | Cash Ratio | 1.89 |
| Debt/Equity | 0.1 | Interest Coverage | 88.08 |
| Altman Z Score | 11.23 | Piotroski Score | 5 |